Mohammad Bagher Owlia

Mohammad Bagher Owlia

Auto-generated profile, based on publicly available information

Mohammad Bagher Owlia

Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2016 in Advances in Pharmacological Sciences
Verified
Journal Article
Open access
PDF file
MGMona Ghasemian
Mona Ghasemian
SOSina Owlia
Sina Owlia
MOMohammad Bagher Owlia
Mohammad Bagher Owlia
Medicinal plants and their secondary metabolites are progressively used in the treatment of diseases as a complementary medicine. Inflammation is a pathologic condition that includes a wide range of diseases such as rheumatic and immune-mediated conditions, diabetes, cardiovascular accident, and etcetera. We introduce some herbs which their anti-inflammatory effects have been evaluated in clinical and experimental studies.Curcuma longa, Zingiber officinale, Rosmarinus officinalis, Borago officinalis, evening primrose, and Devil’s claw are some of the introduced medicinal herbs in this review. Since the treatment of inflammation is not a one-dimensional remedy, this review tries to reach a multidimensional therapeutic approach to inflammation with the help of herbal medicine and modification in lifestyle.

1 May 2013 in Autoimmunity Reviews
Verified
Journal Article
Closed access
KNKam Newman
Kam Newman
MOMohammad Bagher Owlia
Mohammad Bagher Owlia
IEIhab El-Hemaidi
Ihab El-Hemaidi
MAMojtaba Akhtari
Mojtaba Akhtari

8 March 2012 in ISRN Pharmacology
Verified
Journal Article
Open access
PDF file
MOM. B. Owlia
M. B. Owlia
GMG. Mehrpoor
G. Mehrpoor
Behcet’s disease (BD) is the only systemic vasculitis involving both arteries and vein in any sizes. It frequently encounters in rheumatology clinics. It has some major morbidities and even fatal outcomes in some cases. The aim of this paper is to analyze the main concepts on pathophysiology and treatment options in BD, focusing on cardiovascular aspects, thrombosis, and potential future treatment.

17 October 2012 in ISRN Rheumatology
Verified
Journal Article
Open access
PDF file
MOMohammad Bagher Owlia
Mohammad Bagher Owlia
SMSeyed Mohammad Yousof Mostafavi Pour Manshadi
Seyed Mohammad Yousof Mostafavi Pour Manshadi
NNNafiseh Naderi
Nafiseh Naderi
Cardiovascular diseases are common in systemic rheumatologic diseases. They can be presented at the time of diagnosis or after diagnosis. The cardiac involvements can be the first presentation of rheumatologic conditions. It means that a patient with rheumatologic disease may go to a cardiologist when attacked by this disease at first. These manifestations are very different and involve different structures of the heart, and they can cause mortality and morbidity of patients with rheumatologic diseases. Cardiac involvements in these patients vary from subclinical to severe manifestations. They may need aggressive immunosuppressive therapy. The diagnosis of these conditions is very important for choosing the best treatment. Premature atherosclerosis and ischemic heart disease are increased in rheumatoid arthritis and systemic lupus erythematosus, and may be causes of mortality among them. The aggressive control of systemic inflammation in these diseases can reduce the risk of cardiovascular disease especially ischemic heart disease. Although aggressive treatment of primary rheumatologic diseases can decrease mortality rate and improve them, at this time, there are no specific guidelines and recommendations, to include aggressive control and prevention of traditional risk factors, for them.

8 October 2012 in Journal of Dietary Supplements
Verified
Journal Article
Closed access
HMHassan Mozaffari-Khosravi
Hassan Mozaffari-Khosravi
HHHamideh-Al-Sadat Hesabgar
Hamideh-Al-Sadat Hesabgar
MOMohammad-Bagher Owlia
Mohammad-Bagher Owlia
HHHossein Hadinedoushan
Hossein Hadinedoushan
KBKazem Barzegar
Kazem Barzegar
MFMohammad Hossein Fllahzadeh
Mohammad Hossein Fllahzadeh
Introduction: Menopause is one of the important causes of osteoporosis which results from estrogen deficiency. In addition, some clinical and experimental evidence indicates that there is an association between increasing pro-inflammatory cytokine activity and postmenopausal bone loss. The purpose of this study was to determine the effect of garlic tablet on pro-inflammatory cytokines in postmenopausal osteoporotic women. Methods: The present study was a double-blind randomized controlled clinical trial in Yazd conducted during November 2009 until July 2010. The sample included 44 postmenopausal osteoporotic women who were randomly assigned into two groups: the garlic group (GG) and the placebo group (PG). Participants in GG took two garlic tablets daily for 1 month and the participants in PG took placebo tablets in the same manner. Serum interlukin-1, interlukin-6, and tumor necrosis factor alpha (TNF-α) were measured using the ELISA method before and after the intervention. Also, 24-hour dietary recall was recorded for estimation of daily intake of some nutrients. Data were analyzed using SPSS software. Results: There was no statistically significant difference between interlukin-1 and interlukin-6 in the two groups before and after the intervention. The mean of TNF-α did not show any statistically significant difference between the two groups before and after the intervention, but it was significantly reduced by about 47% (from 31.14±50.53 to 19.33±22.19 ng/ml, P-value = 0.05) in GG after the intervention, However, no significant difference was seen in PG. Conclusions: The present study produced some evidence for an immunomodulatory effect of garlic, as well as the modulation of cytokine production.

25 January 2013 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
FBFariba Binesh
Fariba Binesh
MSMostafa Shiryazdi
Mostafa Shiryazdi
MOMohammad Bagher Owlia
Mohammad Bagher Owlia
SASoheila Azimi
Soheila Azimi
Here we report a case of idiopathic granulomatous mastitis (IGM) associated with erythema nodosum (EN) and ankle arthritis. The skin, joint and mammary symptoms improved with corticosteroid. Coincidence of granulomatous mastitis, EN and arthritis is a rare feature.